Centre Hospitalier Universitaire Grenoble Alpes — Sponsor Intelligence | 16 EU Trials

Filter these 16 trials by condition, phase, country and more.

Open in Search →

16 Registered trials

4 Recruiting

7 Completed trials

1 Countries active

19 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 3 Phase II/III: 1 Phase II: 8 Phase I/II: 1 Phase I: 1 Phase I (Other): 1 Other: 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Chronic obstructive pulmonary disease 1 Human herpesvirus 6 encephalitis 1 Depression 1

Top IMPs

BOSENTAN 1 DEXAMETHASONE 1 EDOTREOTIDE 1 ENOXAPARIN SODIUM 1 ESCITALOPRAM 1 EVOLOCUMAB 1 HYDROGEN 1 KETAMINE HYDROCHLORIDE 1 LIDOCAINE HYDROCHLORIDE 1 LIDOCAINE HYDROCHLORIDE MONOHYDRATE 1 MORPHINE HYDROCHLORIDE 1 NEFOPAM HYDROCHLORIDE 1

All trials

16 total

Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation Failure in Acute Exacerbation of Chronic Obstructive Pulmonary D… Pending

2024-516085-11-00 Phase I/II 1 country
Regenerative Stem Cell Therapy for Stroke in Europe 1 Pending

2024-518394-34-00 Phase I 1 country
Effect of H2 inhalation therapy on early recurrence after atrial fibrillation ablation. Pending

2024-520131-33-00 Phase II 1 country HYDROGEN
Etude de phase II évaluant la capacité d'un agoniste des récepteurs 5-HT4, le prucalopride (Resolor©), à accélérer l'efficacité thérapeutiqu… Pending

2025-521811-38-01 Phase II 1 country ESCITALOPRAM; PRUCALOPRIDE SUCCINATE
Intermediate versus standard dose enoxaparin to prevent venous thromboembolism in severe trauma patients: a multicenter double blind randomi… Pending

2025-522832-16-00 Phase II/III 1 country ENOXAPARIN SODIUM; SODIUM CHLORIDE
Evaluation of the efficacy of sphenopalatine block in headache in patients with non-traumatic subarachnoid hemorrhage (SAH) after training o… Recruiting

2024-514282-19-00 Phase II 1 country LIDOCAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE MONOHYDRATE; MORPHINE HYDROCHLO…
Évaluation de la sécurité de l’embolisation par LipiodolⓇ dans l’arthrose digitale symptomatique réfractaire au traitement conventionnel : é… Recruiting

2024-513361-40-00 1 country
Evaluation of the expression of somatostatin receptors in DOTATOC-68Ga PET scans in patients followed for metastatic breast cancer Recruiting

2023-504458-36-02 Phase II 1 country EDOTREOTIDE
Evaluation of the safety of inhaled sedation with Isoflurane in head trauma patients. Recruiting

2023-505729-15-00 Phase II 1 country
Efficacy and Safety of Oral Midazolam for Providing Care to Patients Who Refuse Treatment and Have Moderately Severe to Severe Neurocognitiv… Ended

2023-510277-33-00 Phase II 1 country
Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease needing co… Ended

2024-519012-14-00 Phase II 1 country EVOLOCUMAB
Respiratory effect of the LISA (Less Invasive surfactant administration) method with sedation by propofol versus absence of sedation: Double… Ended

2024-518836-36-00 Phase III 1 country KETAMINE HYDROCHLORIDE; PROPOFOL; TRIGLYCERIDES, MEDIUM CHAIN, SOYA OIL
Evaluation of the effects of bosentan in the management of patients in the acute phase of acute anterior ischemic optic neuropathy. Ended

2024-518345-21-00 Phase III 1 country BOSENTAN
A Proof of Concept Study Non-Randomized, Single-Center Pilot Trial Assessing The Safety/Efficacy Of Dual Targeting Of Peripheral And Central… Ended

2024-518128-66-00 Phase I (Other) 1 country
Urea treatment of hyponatremia in subarachnoid hemorrhage Ended

2024-518532-36-00 Phase II 1 country UREA PH. EUR.
Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months Ended

2024-515985-16-00 Phase III 1 country DEXAMETHASONE

Showing 1–16 of 16 trials

← All sponsors A–Z